Literature DB >> 12852653

Pathogenesis of Kaposi's sarcoma.

Darya Bubman1, Ethel Cesarman.   

Abstract

Kaposi's sarcoma (KS) is a disease characterized by proliferative vascular lesions, which almost invariably contain the KS-associated herpesvirus (KSHV), also called human herpesvirus 8. KSHV is a lymphotrophic and angiotrophic herpesvirus, whose genome encodes several proteins involved in proliferation, antiapoptotic functions, and inflammation. Most KS spindle cells express latent KSHV genes, but a few express lytic genes, which might be involved in angiogenic and paracrine mechanisms that contribute to KS pathogenesis. A number of tissue culture and mouse models have been established, but a comprehensive system that accurately portrays KS pathogenesis still does not exist.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12852653     DOI: 10.1016/s0889-8588(03)00044-3

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  17 in total

1.  Comparative study of Kaposi's sarcoma-associated herpesvirus serological assays using clinically and serologically defined reference standards and latent class analysis.

Authors:  Maria Claudia Nascimento; Vanda Akico de Souza; Laura Masami Sumita; Wilton Freire; Fernando Munoz; Joseph Kim; Claudio S Pannuti; Philippe Mayaud
Journal:  J Clin Microbiol       Date:  2006-12-20       Impact factor: 5.948

2.  Kaposi's sarcoma-associated herpesvirus infection promotes differentiation and polarization of monocytes into tumor-associated macrophages.

Authors:  Natarajan Bhaskaran; Santosh K Ghosh; Xiaolan Yu; Sanhai Qin; Aaron Weinberg; Pushpa Pandiyan; Fengchun Ye
Journal:  Cell Cycle       Date:  2017-07-27       Impact factor: 4.534

3.  Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.

Authors:  Min Hu; Najealicka Armstrong; Edward Seto; Wenwei Li; Fanxiu Zhu; Paul C Wang; Qiyi Tang
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

4.  The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells.

Authors:  Marcos G Grisotto; Alexandre Garin; Andrea P Martin; Kristian K Jensen; Pokman Chan; Stuart C Sealfon; Sergio A Lira
Journal:  J Clin Invest       Date:  2006-04-06       Impact factor: 14.808

5.  Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.

Authors:  Athe M N Tsibris; Roger Paredes; Amy Chadburn; Zhaohui Su; Timothy J Henrich; Amy Krambrink; Michael D Hughes; Judith A Aberg; Judith S Currier; Karen Tashima; Catherine Godfrey; Wayne Greaves; Charles Flexner; Paul R Skolnik; Timothy J Wilkin; Roy M Gulick; Daniel R Kuritzkes
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

6.  Metastatic Kaposi's Sarcoma with Perirectal Involvement Diagnosed with Endoscopic Ultrasound-Guided EchoBrush Cytology Sampling.

Authors:  Daniel Cornett; Mark Benson; Steven Attia; Jennifer Weiss; Deepak Gopal
Journal:  Case Rep Gastroenterol       Date:  2011-07-22

7.  Professional antigen presenting cells in human herpesvirus 8 infection.

Authors:  Emilee R Knowlton; Lauren M Lepone; Jun Li; Giovanna Rappocciolo; Frank J Jenkins; Charles R Rinaldo
Journal:  Front Immunol       Date:  2013-01-21       Impact factor: 7.561

8.  Dangerous liaisons: molecular basis for a syndemic relationship between Kaposi's sarcoma and P. falciparum malaria.

Authors:  Katelyn L Conant; Anita Marinelli; Johnan A R Kaleeba
Journal:  Front Microbiol       Date:  2013-03-12       Impact factor: 5.640

9.  Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.

Authors:  Liviu Feller; Johan Lemmer
Journal:  Infect Agent Cancer       Date:  2008-01-21       Impact factor: 2.965

Review 10.  Role of the ubiquitin system and tumor viruses in AIDS-related cancer.

Authors:  Julia Shackelford; Joseph S Pagano
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.